Does high-sensitivity ST2 improve the prediction of adverse outcomes in patients with chronic heart failure?
High-sensitivity ST2, particularly when combined with NT-proBNP, provides incremental prognostic value over standard clinical risk scores in chronic heart failure.
ST2 is a potent marker of risk in chronic heart failure and when used in combination with NT-proBNP offers moderate improvement in assessing prognosis beyond clinical risk scores.
Ky et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: